Divis Laboratories Signs Long-Term Manufacturing and Supply Agreement with Global Pharma Company

Divis Laboratories Ltd. has entered into a long-term manufacturing and supply agreement with a global pharma company. The agreement covers the manufacturing and supply of advanced intermediates. The company expects meaningful revenue contribution from this agreement. However, due to a confidentiality agreement, the name of the customer and quantitative information pertaining to the agreement cannot be disclosed. Divis Laboratories is also planning for capacity addition at its manufacturing facilities with an estimated investment between INR 650 crores to INR 700 crores, to be funded from internal accruals. This agreement will benefit the customer with assured supply and the company to expand its presence in custom synthesis.